SI1663229T1 - Farmacevtske kombinacije hidrokodona in naltreksona - Google Patents

Farmacevtske kombinacije hidrokodona in naltreksona

Info

Publication number
SI1663229T1
SI1663229T1 SI200431458T SI200431458T SI1663229T1 SI 1663229 T1 SI1663229 T1 SI 1663229T1 SI 200431458 T SI200431458 T SI 200431458T SI 200431458 T SI200431458 T SI 200431458T SI 1663229 T1 SI1663229 T1 SI 1663229T1
Authority
SI
Slovenia
Prior art keywords
naltrexone
hydrocodone
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Application number
SI200431458T
Other languages
English (en)
Inventor
Benjamin Oshlack
Curtis Wright
Chris Breder
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US50622203P priority Critical
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Priority to EP04788669A priority patent/EP1663229B1/en
Priority to PCT/US2004/029521 priority patent/WO2005032555A2/en
Publication of SI1663229T1 publication Critical patent/SI1663229T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
SI200431458T 2003-09-25 2004-09-09 Farmacevtske kombinacije hidrokodona in naltreksona SI1663229T1 (sl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US50622203P true 2003-09-25 2003-09-25
EP04788669A EP1663229B1 (en) 2003-09-25 2004-09-09 Pharmaceutical combinations of hydrocodone and naltrexone
PCT/US2004/029521 WO2005032555A2 (en) 2003-09-25 2004-09-09 Pharmaceutical combinations of hydrocodone and naltrexone

Publications (1)

Publication Number Publication Date
SI1663229T1 true SI1663229T1 (sl) 2010-08-31

Family

ID=42664693

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431458T SI1663229T1 (sl) 2003-09-25 2004-09-09 Farmacevtske kombinacije hidrokodona in naltreksona

Country Status (3)

Country Link
EP (2) EP1663229B1 (sl)
PL (1) PL1663229T3 (sl)
SI (1) SI1663229T1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) * 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (sl) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
NL6714885A (sl) 1967-11-02 1969-05-06
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3916889A (en) 1973-09-28 1975-11-04 Sandoz Ag Patient ventilator apparatus
US4063064A (en) 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4769372A (en) 1986-06-18 1988-09-06 The Rockefeller University Method of treating patients suffering from chronic pain or chronic cough
US4785000A (en) 1986-06-18 1988-11-15 The Rockefeller University Method of treating patients suffering from chronic pain or chronic cough
US4861598A (en) 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
FR2669336B1 (fr) 1990-11-20 1993-01-22 Adir Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5472712A (en) 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5273760A (en) 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
CA2138026C (en) 1992-06-22 2003-09-09 Eckard Weber Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists
US5324351A (en) 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
US5472943A (en) 1992-09-21 1995-12-05 Albert Einstein College Of Medicine Of Yeshiva University, Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
US5604260A (en) 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
US5321012A (en) 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
CA2115792C (en) 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
US5409944A (en) 1993-03-12 1995-04-25 Merck Frosst Canada, Inc. Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5436265A (en) 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
US5475995A (en) 1994-05-16 1995-12-19 Livingston; George G. Truck spare tire locking rod
US5616601A (en) 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5593994A (en) 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
US5552422A (en) 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
US5604253A (en) 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
US5639780A (en) 1995-05-22 1997-06-17 Merck Frosst Canada, Inc. N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US5510368A (en) 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
EP2266564B1 (en) * 1997-12-22 2013-03-13 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and an opioid antagonist
JP2003522146A (ja) * 2000-02-08 2003-07-22 ユーロ−セルティーク,エス.エイ. 外圧に抵抗性の経口オピオイドアゴニスト製剤
AU2002323032B2 (en) * 2001-08-06 2005-02-24 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist

Also Published As

Publication number Publication date
PL1663229T3 (pl) 2010-09-30
EP1663229B1 (en) 2010-04-14
EP1663229A4 (en) 2008-06-11
EP2298303A1 (en) 2011-03-23
EP1663229A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
EP2289512B8 (en) Pharmaceutical foam
DK1855657T3 (da) Doseringsform indeholdende oxycodon og naloxon
GB2406407B (en) Cross-triggering of processing devices
DE60325715D1 (de) Methoden und darreichungsformen zur kontrollierten freisetzung von oxykodon
SG115690A1 (en) Strained-channel transistor and methods of manufacture
EP1677768A4 (en) Extended release formulations of opioids and method of use thereof
AU2003287671A8 (en) People lists
IL238894D0 (en) Maytansinoid derivatives and methods of producing the same
PL375691A1 (xx) Imidazolopirydyny i sposoby ich wytwarzania i stosowania
PT1592686E (pt) Inibidores de girase e suas utilizações
PT1487416E (pt) Micropartículas de fármacos
EP1644943A4 (en) Form-less electronic device and methods of manufacturing
HK1095082A1 (en) Form of administration secured against misuse
PL378072A1 (xx) Pirazole i sposoby ich wytwarzania oraz ich zastosowanie
TW558156U (en) Structure improvement of signal connector
IL182734D0 (en) 4-aminotetracyclines and methods of use thereof
GB0322409D0 (en) Quinazoline derivatives
PL376440A1 (xx) Pochodne pirydopirolizyny i pirydoindolizyny
IL174534D0 (en) Quinazoline derivatives
HK1091486A1 (en) Quinazoline derivatives
ZA200602768B (en) Lipid system and methods of use
DE602004031771D1 (de) Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
EP1814561A4 (en) Therapeutic furopyrimidines and thienopyrimidines
AU2003273171A8 (en) Immunomodulatory compounds and methods of use thereof
SI1587506T1 (sl) Zdravljenje s kapsaicinom